Non-Invasive Chromosomal Evaluation of Trisomy Study
Completed
- Conditions
- Trisomy 13Down SyndromeAneuploidyTrisomy 18Trisomy 21
- Registration Number
- NCT02201862
- Lead Sponsor
- Cindy Cisneros
- Brief Summary
This study is being conducted to provide clinically annotated samples to support continued improvements in the Ariosa Test content, methodology, specimen processing and quality control.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 2000
Inclusion Criteria
-
- Subject is at least 18 years old and can provide informed consent;
-
- Subject has a viable singleton or twin pregnancy;
-
- Subject is confirmed to be at least 10 weeks, 0 days gestation at the time of the study blood draw;
-
- Subject is planning to undergo CVS and/or amniocentesis for the purpose of genetic analysis of the fetus OR the subject has already undergone CVS and/or amniocentesis and is known to have a fetus with a chromosomal abnormality confirmed by genetic analysis.
Exclusion Criteria
-
- Subject has known aneuploidy;
-
- Subject is pregnant with more than two fetuses or has had sonographic evidence of three or more gestational sacs at any time during pregnancy;
-
- Subject has a fetal demise (including natural or elective reduction) identified prior to consent;
-
- Subject has history of malignancy treated with chemotherapy and/or major surgery, or bone marrow transplant;
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of aneuploidy 24 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (3)
Women's Healthcare Group of PA
🇺🇸Oaks, Pennsylvania, United States
Regional Obestrical Consultants
🇺🇸Chattanooga, Tennessee, United States
University California San Diego
🇺🇸San Diego, California, United States